1. Home
  2. CINF vs BNTX Comparison

CINF vs BNTX Comparison

Compare CINF & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cincinnati Financial Corporation

CINF

Cincinnati Financial Corporation

HOLD

Current Price

$156.61

Market Cap

25.0B

Sector

Finance

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$85.38

Market Cap

22.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CINF
BNTX
Founded
1950
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.0B
22.8B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
CINF
BNTX
Price
$156.61
$85.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
13
Target Price
$177.25
$134.15
AVG Volume (30 Days)
610.4K
1.4M
Earning Date
04-27-2026
03-10-2026
Dividend Yield
2.45%
N/A
EPS Growth
4.40
N/A
EPS
15.17
N/A
Revenue
$12,631,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.97
$4.76
P/E Ratio
$10.13
N/A
Revenue Growth
11.41
N/A
52 Week Low
$123.02
$79.81
52 Week High
$174.27
$124.00

Technical Indicators

Market Signals
Indicator
CINF
BNTX
Relative Strength Index (RSI) 41.86 33.93
Support Level $155.14 $79.81
Resistance Level $157.49 $113.12
Average True Range (ATR) 3.35 2.44
MACD -0.83 -0.23
Stochastic Oscillator 20.70 5.79

Price Performance

Historical Comparison
CINF
BNTX

About CINF Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The company operates in segments: Commercial lines insurance, Personal lines insurance, Excess and surplus lines insurance, Life insurance, and Investments. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: